We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+11.24%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$3.67B
(+16%)
Cap. Flow
+$1.33B
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
61.8%
Holding
1,839
New
200
Increased
397
Reduced
428
Closed
156
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$1.63B |
| 2 |
Brookfield Asset Management
BAM
|
+$117M |
| 3 |
ASML
ASML
|
+$86.7M |
| 4 |
Lowe's Companies
LOW
|
+$82.1M |
| 5 |
Oracle
ORCL
|
+$25.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$117M |
| 2 |
Brookfield
BN
|
+$117M |
| 3 |
Meta Platforms (Facebook)
META
|
+$70.7M |
| 4 |
Amazon
AMZN
|
+$62.2M |
| 5 |
Domino's
DPZ
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 49.2% |
| 2 | Technology | 13.2% |
| 3 | Healthcare | 10.72% |
| 4 | Consumer Discretionary | 7.69% |
| 5 | Communication Services | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Enbridge
ENB
$123B
| $57.8M | 0.21% |
1,477,459
-19,303
| -1% | -$755K |
|
52
Pfizer
PFE
$143B
| $57.1M | 0.21% |
1,113,438
-11,152
| -1% | -$535K |
|
53
Canadian Natural Resources
CNQ
$98B
| $53.4M | 0.2% |
1,923,718
-18,914
| -1% | -$540K |
|
|
SCHW
54
Charles Schwab
SCHW
$177B
| $51.7M | 0.19% |
621,435
+177,118
| +40% | +$13.7M |
|
55
United Therapeutics
UTHR
$26.4B
| $51M | 0.19% |
183,400
| – | – |
|
56
Capital One
COF
$123B
| $50.9M | 0.19% |
547,685
+14,784
| +3% | +$1.45M |
|
57
Vanguard S&P 500 ETF
VOO
$967B
| $48.1M | 0.18% |
136,983
-15,320
| -10% | -$5.41M |
|
58
Stryker
SYK
$122B
| $47.1M | 0.17% |
192,692
+16,276
| +9% | +$3.69M |
|
59
Cencora
COR
$59.4B
| $43.1M | 0.16% |
259,887
-20,859
| -7% | -$3.3M |
|
60
Arrowhead Research
ARWR
$12.2B
| $41.6M | 0.15% |
1,025,654
-79,933
| -7% | -$2.65M |
|
61
Walt Disney
DIS
$161B
| $41.1M | 0.15% |
472,862
-69,789
| -13% | -$6.68M |
|
62
Procter & Gamble
PG
$342B
| $41M | 0.15% |
275,209
-5,557
| -2% | -$779K |
|
63
IQVIA
IQV
$34.6B
| $40M | 0.15% |
195,145
-6,676
| -3% | -$1.35M |
|
64
Moody's
MCO
$82.5B
| $40M | 0.15% |
143,394
-1,844
| -1% | -$504K |
|
|
HOLX
65
DELISTED
Hologic
HOLX
| $38.7M | 0.14% |
516,766
+66
| +0% | +$4.7K |
|
66
JPMorgan Chase
JPM
$930B
| $36.9M | 0.14% |
276,937
-3,667
| -1% | -$465K |
|
67
Ingredion
INGR
$6.32B
| $36.3M | 0.13% |
370,470
-4,186
| -1% | -$386K |
|
68
Amgen
AMGN
$201B
| $36M | 0.13% |
139,782
-4,478
| -3% | -$1.2M |
|
69
Match Group
MTCH
$8.72B
| $35.7M | 0.13% |
859,983
-296,156
| -26% | -$13.4M |
|
70
Immunocore
IMCR
$1.81B
| $35M | 0.13% |
613,749
-182,100
| -23% | -$10.2M |
|
71
AB InBev
BUD
$155B
| $35M | 0.13% |
583,147
-52,465
| -8% | -$2.82M |
|
72
Graco
GGG
$12.6B
| $34.6M | 0.13% |
549,773
+144,045
| +36% | +$9.61M |
|
73
Starbucks
SBUX
$118B
| $33.7M | 0.12% |
374,212
-38,199
| -9% | -$3.6M |
|
74
Eli Lilly
LLY
$1.06T
| $32.2M | 0.12% |
88,070
-33,078
| -27% | -$11.7M |
|
75
Evolus
EOLS
$394M
| $30.2M | 0.11% |
4,016,138
-18,800
| -0.5% | -$146K |
|
Similar funds
SAM
First Manhattan's Q4 2022 Portfolio in Review
As of Q4 2022, First Manhattan held 1,839 positions worth $27.3B, up 16% from $23.6B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
First Manhattan deployed $1.33B of net new capital in Q4 2022, opening 200 new positions and adding to 397 existing holdings. Its largest new stake was Brookfield Asset Management: 3,875,454 shares worth $111M.
By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 44% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $117M trimmed.
- First Manhattan's largest Q4 2022 buy was Brookfield Asset Management: 3,875,454 shares worth $111M.
- First Manhattan added most to Berkshire Hathaway Class A in Q4 2022, an estimated $1.63B increase.
- First Manhattan's biggest Q4 2022 reduction was Apple, cutting an estimated $117M.
- First Manhattan fully exited Alleghany Corp in Q4 2022, selling an estimated $1.07M.
- First Manhattan's ten largest holdings make up 62% of its $27.3B portfolio in Q4 2022.
- First Manhattan opened 200 new positions and closed 156 in Q4 2022.
- First Manhattan's portfolio value rose 16% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.